Lewy bodies - PubMed (original) (raw)

Lewy bodies

Clifford W Shults. Proc Natl Acad Sci U S A. 2006.

Abstract

Lewy bodies (LB) in the substantia nigra are a cardinal pathological feature of Parkinson's disease, but they occur in a number of neurodegenerative diseases and can be widespread in the nervous system. The characteristics, locations, and composition of LB are reviewed, with particular attention to alpha-synuclein (alpha-SYN), which appears to be the major component of LB. The propensity for alpha-SYN, a presynaptic protein widely expressed in the brain, to aggregate is because of an amyloidogenic central region. The factors that favor the aggregation of alpha-SYN and mechanisms of toxicity are examined, and a mechanism through which aggregates of alpha-SYN could induce mitochondrial dysfunction and/or release of proapoptotic molecules is proposed.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: No conflicts declared.

References

    1. Braak H., Del Tredici K., Rub U., de Vos R. A., Jansen Steur E. N., Braak E. Neurobiol. Aging. 2003;24:197–211. - PubMed
    1. Lewy F. H. In: Handbuch der Neurologie. Lewandowsky M, editor. Vol. III. Berlin: Springer; 1912. pp. 920–933.
    1. Forno L. S. J. Neuropathol. Exp. Neurol. 1996;55:259–272. - PubMed
    1. Pollanen M. S., Dickson D. W., Bergeron C. J. Neuropathol. Exp. Neurol. 1993;52:183–191. - PubMed
    1. Norris E. H., Giasson B. I. Antioxid. Redox Signaling. 2005;7:673–684. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources